A recent study has raised concerns about nifedipine, a commonly prescribed medication for high blood pressure and chest pain. The research reveals that high doses of this drug may significantly increase the risk of sudden cardiac arrest, prompting caution among both doctors and patients.
Sudden cardiac arrest is a life-threatening condition where the heart stops pumping blood effectively, leading to unconsciousness and a cessation of breathing. Without immediate medical intervention, such as CPR or defibrillation, it is often fatal.
It is responsible for half of all heart-related deaths in Europe and one in every five natural deaths globally. Although some individuals may experience warning signs like chest pain or shortness of breath, it often occurs without warning, making it particularly dangerous.
The study, part of the Dutch Amsterdam Resuscitation Studies (ARREST) registry, examined the effects of two drugs used to manage high blood pressure and chest pain: nifedipine and amlodipine.
Researchers analyzed data from over 2,500 patients who experienced sudden cardiac arrest, comparing it with information from more than 10,000 healthy individuals.
The results were alarming. Patients taking high doses of nifedipine (60 mg per day) faced a significantly higher risk of sudden cardiac arrest compared to those not on the drug. In contrast, amlodipine, a similar medication, did not show the same elevated risk.
To confirm these findings, the team analyzed data from the Danish Cardiac Arrest Registry, involving over 8,000 patients and 40,000 control subjects. The Danish data supported the original results, reinforcing concerns about high-dose nifedipine.
This discovery is unsettling, as nifedipine and amlodipine have been widely used for many years, helping millions of people manage their heart health. The potential risks associated with nifedipine, especially at high doses, may have been overlooked in earlier studies due to the unpredictable nature of sudden cardiac arrest. Unlike conditions with more gradual symptoms, sudden cardiac arrest occurs quickly, making it difficult to study comprehensively.
While the researchers are not calling for an immediate ban on nifedipine, they urge caution. Doctors and patients should have open discussions about the potential risks, particularly when prescribing or using high doses of the drug.
This study highlights the importance of personalized treatment decisions and the need to weigh the benefits and risks of any medication carefully.
The findings also underscore the importance of ongoing research to monitor the safety of widely used medications. Even drugs with a long history of use, like nifedipine, may carry hidden risks that only come to light through large-scale studies like this one.
Patients currently taking nifedipine should not stop their medication without consulting their doctor, as sudden changes in treatment can be harmful. Instead, they are encouraged to speak with their healthcare providers to explore their options and ensure they are receiving the safest and most effective care for their condition.
In conclusion, this study highlights a serious potential risk linked to high doses of nifedipine, emphasizing the need for caution and informed decision-making. As research continues, both doctors and patients must stay vigilant, ensuring treatments prioritize safety while effectively managing health conditions.
If you care about blood pressure, please read studies about unhealthy habits that could increase high blood pressure risk, and eating eggs in a healthy diet may reduce risks of diabetes, high blood pressure.
For more information about blood pressure, please see recent studies that early time-restricted eating could help improve blood pressure, and results showing 12 foods that lower blood pressure.
Copyright © 2025 Knowridge Science Report. All rights reserved.
